Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT02064764
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 102 participants
- Sponsor
- Registry
-
NCT02064764
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Germany
- Registry status
- Completed
Technical summary
Registry record NCT02064764. Randomized; no masking; primary purpose treatment. Start 2015-02 (actual); primary completion 2021-04-19 (actual). Results posted on 2024-02-23.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Renal Nerve Denervation in Patients With Hypertension and Paroxysmal and Persistent Atrial Fibrillation
- Acronym
- Symplicity AF
- Condition
- Atrial Fibrillation
- Condition
- Hypertension
- Intervention (Device)
- Symplicity Spyral™ Multi-Electrode Renal Denervation Catheter
- Intervention (Device)
- Arctic Front Advance™ Cardiac Cryoablation System
- Lead sponsor
- Medtronic Vascular
Record details
- Record id
cardio:ct-nct02064764- Content hash
e54a91f757acd4a5f9375a59fcda9e2c17001081f12e3880f2477de03e9a3214